CD44 and cancer: Kure et al. examined the expression of cancer stem cell markers (CD24, CD44, CD133, CXCR4, ESA, Nestin) in pancreatic intraepithelial neoplasia (PanIN) and PDAC by using immunohistochemistry (IHC) or flow cytometry (FCM) [36].